ArticleContemporary clinical trials2018

Study design considerations for the Standardized Treatment of Pulmonary Exacerbations 2 (STOP2): A trial to compare intravenous antibiotic treatment durations in CF.

Sonya L Heltshe et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.